Clinical Trial

Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In study phase 1, the investigators will prospectively examine the factors related to post-operative glycemic variability and its effect on outcomes in people with both DM and GI cancer after surgery. The study will also qualitatively understand the glycemic variability experiences and their associated symptoms and outcomes in people with both DM and GI cancer. In study phase 2, the investigators will develop and test the effects of the CGM-Assisted Reflection Education (CARE) program on adults with both DM and GI cancer post-surgery.
Trial Details
NCT Number NCT07180251
Lead Sponsor National Taiwan University Hospital
Conditions Diabetes Melletus, Gastrointestinal Cancers
Enrollment 260 participants
Start Date 2025-09-08
Primary Completion 2028-07-31 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-18